tetrahydrocannabinol (THC)

article

Cannabinoids in pharma series: the future prospects of cannabinoids

27 August 2019 | By Victoria Rees (European Pharmaceutical Review)

This series investigates cannabinoids and pharmaceutical interest with industry experts explaining the position of the ingredient. In this third piece, we discuss the future of the cannabinoid industry and how it will grow within the realm of pharmaceuticals.

article

Cannabinoids in pharma series: the challenges of working with cannabinoids

20 August 2019 | By Victoria Rees (European Pharmaceutical Review)

This series investigates cannabinoids and pharmaceutical interest with industry experts explaining the position of the ingredient. In this second piece, we discuss the challenges, legal implications and perceptions of cannabinoids.